Asthma is a globally significant non-communicable disease with major public health
consequences for both children and adults, including high morbidity, and mortality in severe …

Asthma treatment goals currently focus on symptom and exacerbation control rather than
remission. Remission is not identical to cure, but is a step closer. This review considers the …

This review of trends in worldwide asthma prevalence starts with defining how asthma
prevalence is measured in populations and how it is analysed. Four population studies of …

Asthma is the most common chronic disease in children, imposing a consistent burden on
health system. In recent years, prevalence of asthma symptoms became globally increased …

Asthma varies considerably across the life course. Childhood asthma is known for its overall
high prevalence with a male predominance prior to puberty, common remission, and rare …

About 334 million people worldwide suffer from asthma, and this figure may be an
underestimation. It is the most common chronic disease in children. Asthma is among the top …

Background Maximal lung function in early adulthood is an important determinant of
mortality and COPD. We investigated whether distinct trajectories of lung function are …

Allergen immunotherapy (AIT) is a proven therapeutic option for the treatment of allergic
rhinitis and/or asthma. Many guidelines or national practice guidelines have been produced …

This review focuses on recent clinical and translational discoveries in severe and
uncontrolled asthma that now enable phenotyping and personalized therapies in these …

Asthma is the most prevalent chronic respiratory disease both in children and adults and
resembles a complex syndrome rather than a single disease. Different methods have been …